Qi Guo1, Hui Zhang1, Ling Zhang2, Yang He1, Shaobo Weng3, Ziping Dong4, Jianmin Wang1, Pingfang Zhang1, Ribu Nao4. 1. Orthopedics Department I, General Hospital of North China Petroleum Administration Renqiu 062552, P.R. China. 2. Orthopedics Department II, General Hospital of North China Petroleum Administration Renqiu 062552, P.R. China. 3. Department of Urology, General Hospital of North China Petroleum Administration Renqiu 062552, P.R. China. 4. Department of Emergency, General Hospital of North China Petroleum Administration Renqiu 062552, P.R. China.
Abstract
AIMS: This study is to investigate the regulatory effect of microRNA-21 (miR-21) on bone metastasis of non-small cell lung cancer (NSCLC). METHODS: In this study, 18 patients were diagnosed with vertebral column metastasis of NSCLC. MiR-21 or small interfering RNAs were transfected into H2170 cells using Lipofectamine 2000. Real-time PCR was performed to detect miR-21 expression. Western blotting was used to measure the expression of COX-19 protein. Enzymatic activity tests were performed to measure the activity of cytochrome C oxidase. Flow cytometry was used to monitor changes in cell apoptotic rate. MTT assay was used to determine the capability of cell proliferation. RESULTS: Bone metastasis of NSCLC enhanced the levels of miR-21 in NSCLC patients. Proliferation capability of cells with high expression of miR-21 was greater than that of cells with the inhibition of miR-21 expression. High expression of miR-21 promoted cell proliferation by inhibiting cell apoptosis. COX-19 was a key factor in the inhibition of apoptosis by miR-21. Inhibition of COX-19 expression reduced cell proliferation by enhancing cell apoptosis. CONCLUSIONS: This study demonstrates that inhibition of miRNA-21 suppresses NSCLC cell proliferation by promoting cell apoptosis via the decrease of COX-19 expression.
AIMS: This study is to investigate the regulatory effect of microRNA-21 (miR-21) on bone metastasis of non-small cell lung cancer (NSCLC). METHODS: In this study, 18 patients were diagnosed with vertebral column metastasis of NSCLC. MiR-21 or small interfering RNAs were transfected into H2170 cells using Lipofectamine 2000. Real-time PCR was performed to detect miR-21 expression. Western blotting was used to measure the expression of COX-19 protein. Enzymatic activity tests were performed to measure the activity of cytochrome C oxidase. Flow cytometry was used to monitor changes in cell apoptotic rate. MTT assay was used to determine the capability of cell proliferation. RESULTS: Bone metastasis of NSCLC enhanced the levels of miR-21 in NSCLCpatients. Proliferation capability of cells with high expression of miR-21 was greater than that of cells with the inhibition of miR-21 expression. High expression of miR-21 promoted cell proliferation by inhibiting cell apoptosis. COX-19 was a key factor in the inhibition of apoptosis by miR-21. Inhibition of COX-19 expression reduced cell proliferation by enhancing cell apoptosis. CONCLUSIONS: This study demonstrates that inhibition of miRNA-21 suppresses NSCLC cell proliferation by promoting cell apoptosis via the decrease of COX-19 expression.
Entities:
Keywords:
Bone metastasis; COX-19; apoptosis; cytochrome C oxidase; microRNA-21; non-small cell lung cancer
Authors: George Adrian Calin; Calin Dan Dumitru; Masayoshi Shimizu; Roberta Bichi; Simona Zupo; Evan Noch; Hansjuerg Aldler; Sashi Rattan; Michael Keating; Kanti Rai; Laura Rassenti; Thomas Kipps; Massimo Negrini; Florencia Bullrich; Carlo M Croce Journal: Proc Natl Acad Sci U S A Date: 2002-11-14 Impact factor: 11.205
Authors: M Suter; C Remé; C Grimm; A Wenzel; M Jäättela; P Esser; N Kociok; M Leist; C Richter Journal: J Biol Chem Date: 2000-12-15 Impact factor: 5.157
Authors: Inga Newie; Rolf Søkilde; Helena Persson; Thiago Jacomasso; Andrej Gorbatenko; Åke Borg; Michiel de Hoon; Stine F Pedersen; Carlos Rovira Journal: Sci Rep Date: 2016-10-18 Impact factor: 4.379